C07C 275/32
Being further substituted by singly-bound oxygen atoms
Official title: being further substituted by singly-bound oxygen atoms
C07C275/32 (Being further substituted by singly-bound oxygen atoms) appears on 433 US grants and 387 published applications in this corpus.
Search patents in C07C- Granted patents
- 433
- Published applications
- 387
- Assignees
- 256
- Inventors
- 1,432
- Latest grant
- 18 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 9 | 0 |
| 1977 | 10 | 0 |
| 1978 | 10 | 0 |
| 1979 | 3 | 0 |
| 1980 | 4 | 0 |
| 1981 | 10 | 0 |
| 1982 | 6 | 0 |
| 1983 | 9 | 0 |
| 1984 | 4 | 0 |
| 1985 | 2 | 0 |
| 1986 | 1 | 0 |
| 1987 | 2 | 0 |
| 1988 | 3 | 0 |
| 1989 | 5 | 0 |
| 1990 | 8 | 0 |
| 1991 | 3 | 0 |
| 1992 | 3 | 0 |
| 1993 | 6 | 0 |
| 1994 | 6 | 0 |
| 1995 | 12 | 0 |
| 1996 | 4 | 0 |
| 1997 | 10 | 0 |
| 1998 | 7 | 0 |
| 1999 | 10 | 0 |
| 2000 | 9 | 0 |
| 2001 | 13 | 7 |
| 2002 | 19 | 19 |
| 2003 | 12 | 32 |
| 2004 | 20 | 29 |
| 2005 | 7 | 24 |
| 2006 | 14 | 20 |
| 2007 | 13 | 19 |
| 2008 | 17 | 21 |
| 2009 | 10 | 27 |
| 2010 | 15 | 12 |
| 2011 | 13 | 17 |
| 2012 | 19 | 23 |
| 2013 | 8 | 13 |
| 2014 | 15 | 15 |
| 2015 | 11 | 11 |
| 2016 | 7 | 7 |
| 2017 | 5 | 14 |
| 2018 | 10 | 11 |
| 2019 | 9 | 10 |
| 2020 | 14 | 13 |
| 2021 | 5 | 11 |
| 2022 | 6 | 5 |
| 2023 | 1 | 7 |
| 2024 | 6 | 9 |
| 2025 | 6 | 6 |
| 2026 | 2 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- RXFP1 agonists18 Aug 2026US 12,709,594 B2Bristol-Myers Squibb Company
- Urea derivatives and their use as curatives and curative accelerators for resin systems5 May 2026US 12,617,753 B2Hexcel Composites Limited
- Hydroxybenzamide derivatives and methods of use in treating diabetes30 Dec 2025US 12,509,429 B2The Board of Regents of the University of Oklahoma
- Imaging histone deacetylases with a radiotracer using positron emission tomography9 Dec 2025US 12,491,270 B2The General Hospital Corporation
- Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-1715 Jul 2025US 12,358,866 B2Reata Pharmaceuticals Holdings, LLC
- Novel carboxamide derivatives8 Oct 2026US 2026/0308149 A1Angelini Pharma S.P.A.
- Fluorinated fluorine-containing compound, and fluorine-containing fluoropolymer and surface treatment agent using same30 Jul 2026US 2026/0217641 A1AGC Inc.
- Prodrugs of dimethoxyphenylalkylamine activators of serotonin receptors23 Jul 2026US 2026/0207636 A1
- Bromodomain inhibitors for cancer therapy18 Jun 2026US 2026/0167646 A1University of Tennessee Research Foundation
- Carbamate compound9 Apr 2026US 2026/0098022 A1Mitsui Chemicals, Inc.
Most cited
By later US patents
- Urea derivatives and their use as ACAT inhibitors134US 5,621,010 ANisshin Flour Milling Co., Ltd. · 1997
- IL-8 receptor antagonists92US 5,886,044 ASmithKline Beecham Corporation · 1999
- IL-8 receptor antagonists88US 5,780,483 ASmithKline Beecham Corporation · 1998
- Process for sizing paper with anionic hydrophobic sizing agents and cationic retention aids87US 4,956,049 ACiba-Geigy Corporation · 1990
- IL-8 receptor antagonists84US 6,005,008 ASmithKline Beecham Corporation · 1999